The Cost-Effectiveness of Increased Yogurt Intake in Type 2 Diabetes in Japan
Nutrients · 2025
DOI: 10.3390/nu17142278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Ryota Wakayama und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Health and Nutrition, National Institutes of Biochemical Innovation, Health and Nutrition, 3-17 Senriokashimmachi, Settsu 566-0…. Hauptthemen laut MEDLINE: Yogurt, Diabetes Mellitus, Type 2, Cost-Benefit Analysis, Diet, Healthy. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health Labour and Welfare, Ajinomoto (Japan), Ezaki Glico (Japan).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: A healthy diet helps prevent noncommunicable diseases, and dairy is an essential part of this diet. Multiple meta-analyses have shown an inverse association between yogurt intake and type 2 diabetes (T2D). This study aimed to develop a simulation model and evaluate the medical and economic effects of increased yogurt intake on T2D.
Methods
It predicted the T2D incidence rate, T2D mortality rate, and national healthcare expenditures (NHE) over 10 years using a Markov model for the Japanese population aged 40–79 years.
Results
By increasing yogurt intake to 160 g/day or 80 g/day, the incidence rate of T2D decreased by 16.1% or 5.9%, the T2D-related mortality rate decreased by 1.6% or 0.6%, and the NHE was predicted to decrease by 2.4% and 0.9%, respectively.
Conclusions
Increasing yogurt intake may be an effective strategy to prevent T2D and reduce NHE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute of Health and Nutrition, National Institutes of Biochemical Innovation, Health and Nutrition, 3-17 Senriokashimmachi, Settsu 566-0002, Osaka, Japan.
- Meiji Co., Ltd., 2-2-1 Kyobashi, Chuo-ku 104-8306, Tokyo, Japan.
- Department of Pharmaceutical Sciences, College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Noji-higashi, Kusatsu 525-8577, Shiga, Japan.
ORCID-Profile: Ryota Wakayama, Mieko Nakamura, Nayu Ikeda
Förderung
- Ministry of Health Labour and Welfare
- Ajinomoto (Japan)
- Ezaki Glico (Japan)
- KAGOME (Japan)
- Kikkoman (Japan)
- ZENSHO HOLDINGS (Japan)
- NISSIN FOOD HOLDINGS (Japan)
- Nissui (Japan)
Zitieren
APA
Wakayama, R., Araki, M., Nakamura, M., & Ikeda, N. (2025). The Cost-Effectiveness of Increased Yogurt Intake in Type 2 Diabetes in Japan. Nutrients. https://doi.org/10.3390/nu17142278
Vancouver
Wakayama R, Araki M, Nakamura M, Ikeda N. The Cost-Effectiveness of Increased Yogurt Intake in Type 2 Diabetes in Japan. Nutrients. 2025. doi:10.3390/nu17142278
BibTeX
@article{Wakayama2025,
author = {Wakayama, Ryota and Araki, Michihiro and Nakamura, Mieko and Ikeda, Nayu},
title = {The Cost-Effectiveness of Increased Yogurt Intake in Type 2 Diabetes in Japan},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17142278}
}
EUVIMED